Patent · US Active

Truncated somatostatin receptors

US8278066B2 · kind B2 · utility

3Cited by
7References
15Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 6, 2011
Grant dateOct 2, 2012
Priority date—
Expiry dateSep 6, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention is directed to fusion proteins that can be used to assay gene transfer and expression both in vitro and in vivo. The fusion proteins contain a reporter protein, e.g. a somatostatin receptor, fused to a second protein, which may be a protein fusion tag. Alternatively, a fusion protein may be fused to a leader sequence. A leader sequence may localize an expressed protein, e.g. localize a fusion protein to the cell membrane. The invention includes nucleic acids encoding the fusion proteins and methods of assaying for gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.